Levobac TS Is indicated for the treatment of corneal ulcer caused by susceptibe strains of bacteria:

Dosage & Administration

Days 1 through 3:
Instill one to two drops in the affected eye(s) every 30 minutes to 2 hours while awake and approximately 4 and 6 hours after retiring.
Day 4 through treatment completion:
Instill one to two drops in the affected eye(s) every 1 to 4 hours while awake.


As with other anti-infective, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If super-infection occurs, discontinue use and institute alternative therapy. Patients should be advised not to wear contact lenses if they have signs and symptoms of bacterial conjunctivitis.
Use In Pregnancy
There are no adequate and well controlled studies in pregnant women. Levofloxacin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Use In Nursing Mothers
Levofloxacin has not been measured in human milk. Based upon data from Ofloxacin it can be presumed that Levofloxacin is excreted in human milk. Caution should be exercised when Levobac is administered to a nursing mother.
Pediatric Use
Safety and efficacy in infants below the age of 1 year have not been established.

Product Details

Related Products

Besibac Eye Drops

Besifloxacin 0.6%

Moxibac Eye Drops

Moxifloxacin 0.5%

Lomebac Eye Drops

Lomefloxacin 0.3%

Tobrabac Eye Drops

Tobramycin 0.3%